Your browser doesn't support javascript.
Intermediate versus standard dose heparin prophylaxis in COVID-19 ICU patients: A propensity score-matched analysis.
Moll, Matthew; Zon, Rebecca L; Sylvester, Katelyn W; Rimsans, Jessica; Chen, Evan C; Ghosh, Auyon J; Abston, Eric; Kim, Andy; Rutherford, Henry; Mitre, Xhoi; Hakim, Aaron; Connell, Nathan T; Battinelli, Elisabeth; Fredenburgh, Laura E; Baron, Rebecca M; Hobbs, Brian D; Cho, Michael H; Mittleman, Murray A; Woolley, Ann E; Connors, Jean M.
  • Moll M; Channing Division of Network Medicine, Brigham and Women's Hospital, Boston, MA, USA; Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Boston, MA, USA.
  • Zon RL; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Sylvester KW; Department of Pharmacy Services, Brigham and Women's Hospital, Boston, MA, USA.
  • Rimsans J; Department of Pharmacy Services, Brigham and Women's Hospital, Boston, MA, USA.
  • Chen EC; Hematology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Ghosh AJ; Channing Division of Network Medicine, Brigham and Women's Hospital, Boston, MA, USA; Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Boston, MA, USA.
  • Abston E; Division of Thoracic Surgery, Department of Surgery, Massachusetts General Hospital, Boston, MA.
  • Kim A; Department of Infectious Diseases, Brigham and Women's Hospital, Boston, MA, USA.
  • Rutherford H; Department of Infectious Diseases, Brigham and Women's Hospital, Boston, MA, USA.
  • Mitre X; Department of Infectious Diseases, Brigham and Women's Hospital, Boston, MA, USA.
  • Hakim A; Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA, USA.
  • Connell NT; Division of Hematology, Brigham and Women's Hospital, Boston, MA, USA.
  • Battinelli E; Division of Hematology, Brigham and Women's Hospital, Boston, MA, USA.
  • Fredenburgh LE; Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Boston, MA, USA.
  • Baron RM; Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Boston, MA, USA.
  • Hobbs BD; Channing Division of Network Medicine, Brigham and Women's Hospital, Boston, MA, USA; Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Boston, MA, USA.
  • Cho MH; Channing Division of Network Medicine, Brigham and Women's Hospital, Boston, MA, USA; Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Boston, MA, USA.
  • Mittleman MA; Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA, USA; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
  • Woolley AE; Department of Infectious Diseases, Brigham and Women's Hospital, Boston, MA, USA.
  • Connors JM; Hematology, Dana-Farber Cancer Institute, Boston, MA, USA; Division of Hematology, Brigham and Women's Hospital, Boston, MA, USA. Electronic address: jconnors@bwh.harvard.edu.
Thromb Res ; 203: 57-60, 2021 07.
Article in English | MEDLINE | ID: covidwho-1211154
Subject(s)
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Heparin / COVID-19 Type of study: Observational study / Prognostic study Limits: Humans Language: English Journal: Thromb Res Year: 2021 Document Type: Article Affiliation country: J.thromres.2021.04.009

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Heparin / COVID-19 Type of study: Observational study / Prognostic study Limits: Humans Language: English Journal: Thromb Res Year: 2021 Document Type: Article Affiliation country: J.thromres.2021.04.009